SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-003493
Filing Date
2017-03-06
Accepted
2017-03-06 17:11:27
Documents
71
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cort-10k_20161231.htm 10-K 2539082
2 EX-23.1 cort-ex231_10.htm EX-23.1 5620
3 EX-31.1 cort-ex311_9.htm EX-31.1 15190
4 EX-31.2 cort-ex312_8.htm EX-31.2 15180
5 EX-32.1 cort-ex321_6.htm EX-32.1 6801
6 EX-32.2 cort-ex322_7.htm EX-32.2 6779
7 GRAPHIC g2017030620571215425445.jpg GRAPHIC 27872
  Complete submission text file 0001564590-17-003493.txt   8658294

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cort-20161231.xml EX-101.INS 2075232
9 XBRL TAXONOMY EXTENSION SCHEMA cort-20161231.xsd EX-101.SCH 48039
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20161231_cal.xml EX-101.CAL 49588
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20161231_def.xml EX-101.DEF 122850
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20161231_lab.xml EX-101.LAB 381037
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20161231_pre.xml EX-101.PRE 283484
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 17668759
SIC: 2834 Pharmaceutical Preparations